SEC Form 4 · Rule 10b5-1 trading plans
KALA BIO, Inc. (KALA)
- 5Trades filed under a plan
- 0Plan adoption dates stated
- 0Quarterly results prints on file
- 0Trades in the days before a print
In the 2025 filing year, KALA BIO, Inc. filed 5 Form 4 statements whose footnotes name a Rule 10b5-1 trading plan, by 5 reporting owners, covering 5 transactions filed under those plans and 13,945 shares. None carries the SEC's own AFF10B5ONE adoption flag; each of the 5 names a plan in a footnote. No results print is on file in this window, so no interval is measured.
Trades filed under a plan in KALA BIO, Inc. 5
- Bazemore Todd — 2025-01-06 · S · 1,993 shares
- Brazzell Romulus K — 2025-01-06 · S · 2,446 shares
- Iwicki Mark T — 2025-01-06 · S · 5,779 shares
- Kharabi Darius — 2025-01-06 · S · 2,021 shares
- Reumuth Mary — 2025-01-06 · S · 1,706 shares
Plan adoption dates stated in KALA BIO, Inc. 0
Quarterly results prints on file in KALA BIO, Inc. 0
Trades in the days before a print in KALA BIO, Inc. 0
Interval to the next reported results date
For each transaction filed under a plan, the days between the transaction date and the company’s next results print. These are the dates the filings state, printed as an interval; the page draws no conclusion from them.
- 0Within 5 days of a print
- 0Within 10 days of a print
- —Shortest interval, in days
- 5Trades with no later print on file
Order the document
Every company with plan records →
Form 4 statements and their footnotes from the SEC’s EDGAR full-text search, and this company’s results dates, industry classification and state of incorporation from the SEC submissions API. The page prints the dates the filings state and the interval between them; it draws no conclusion from them.